Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation

Erin A. Fender, Jawad G. Kiani, David Holmes

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Purpose of Review: Anticoagulant therapy effectively reduces the incidence of stroke in patients with atrial fibrillation (AF) but is underutilized and frequently contraindicated. The left atrial appendage (LAA) is the primary site of thrombus formation in AF patients. Surgical and percutaneous appendage closure has been evaluated as a site-specific therapy to reduce systemic thromboembolism. Recent Findings: We will review LAA closure techniques, examine recent outcome data, and discuss the indications for, and potential complications of, each approach. Summary: Randomized data examining surgical LAA closure and epicardial closure with the LARIAT device are lacking. High quality, randomized data supports the efficacy of the WATCHMAN device for stroke prevention in patients with AF.

Original languageEnglish (US)
Article number65
JournalCurrent atherosclerosis reports
Issue number11
StatePublished - Nov 1 2016


  • Atrial fibrillation
  • Lariat
  • Left atrial appendage closure
  • Stroke
  • Watchman

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation'. Together they form a unique fingerprint.

Cite this